Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells

Molecular Pharmacology
Burkhard HinzKay Brune

Abstract

Cannabinoids have been implicated in the reduction of glioma growth. The present study investigated a possible relationship between the recently shown induction of cyclooxygenase (COX)-2 expression by the endocannabinoid analog R(+)methanandamide [R(+)-MA] and its effect on the viability of H4 human neuroglioma cells. Incubation with R(+)-MA for up to 72 h decreased the cellular viability and enhanced accumulation of cytoplasmic DNA fragments in a time-dependent manner. Suppression of R(+)-MA-induced prostaglandin (PG) E2 synthesis with the selective COX-2 inhibitor celecoxib (0.01-1 microM) or inhibition of COX-2 expression by COX-2-silencing small-interfering RNA was accompanied by inhibition of R(+)-MA-mediated DNA fragmentation and cell death. In contrast, the selective COX-1 inhibitor SC-560 was inactive in this respect. Cells were also protected from apoptotic cell death by other COX-2 inhibitors (NS-398 [[N-[2-(cyclohexyloxy)-4-nitrophenyl]-methanesulfonamide]] and diclofenac) and by the ceramide synthase inhibitor fumonisin B1, which interferes with COX-2 expression by R(+)-MA. Moreover, the proapoptotic action of R(+)-MA was mimicked by the major COX-2 product PGE2. Apoptosis and cell death by R(+)-MA were not affected...Continue Reading

References

Sep 1, 1975·Journal of the National Cancer Institute·A E MunsonR A Carchman
Jan 1, 1991·Life Sciences·M Perez-ReyesR E Hicks
Apr 16, 1998·Biochemical and Biophysical Research Communications·G BagettaA Finazzi-Agrò
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Jul 21, 2001·Ophthalmic Research·K GreenO L McIntyre
Oct 19, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S GröschG Geisslinger
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Burkhard Hinz, Kay Brune
Mar 16, 2002·Neoplasia : an International Journal for Oncology Research·Daniel H HwangAndrew J Dannenberg
Mar 20, 2002·Nature Reviews. Cancer·R A Gupta, R N Dubois
Mar 21, 2002·The Biochemical Journal·Teresa Gómez del PulgarManuel Guzmán
May 16, 2002·The Biochemical Journal·Mauro MaccarroneAlessandro Finazzi-Agrò
Jun 11, 2002·Methods : a Companion to Methods in Enzymology·Sayda M ElbashirThomas Tuschl
Dec 18, 2002·Annals of the New York Academy of Sciences·Hye-Kyung Na, Young-Joon Surh
Feb 1, 2003·Trends in Pharmacological Sciences·Kotha Subbaramaiah, Andrew J Dannenberg
Aug 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maurizio BifulcoVincenzo DI Marzo

❮ Previous
Next ❯

Citations

Nov 1, 2011·Cancer Metastasis Reviews·Daniel J Hermanson, Lawrence J Marnett
Mar 31, 2005·Microvascular Research·Ping ChenXiang Fang
Apr 7, 2009·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Simo MattilaFrej Stenbäck
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Sep 17, 2009·Molecular Cancer Therapeutics·Heath A ElrodShi-Yong Sun
Nov 15, 2013·International Journal of Endocrinology·B M FonsecaN A Teixeira
Jul 11, 2008·PPAR Research·Heath A Elrod, Shi-Yong Sun
Aug 10, 2010·Pharmaceuticals·Michelle Roche, David P Finn
Mar 12, 2013·Prostaglandins & Other Lipid Mediators·B M FonsecaN A Teixeira
Oct 30, 2012·Progress in Lipid Research·Iain BrownKlaus W J Wahle
Jun 23, 2009·European Journal of Pharmacology·Tonia LucaGiuseppina Cantarella
Sep 29, 2005·Biomedical Chromatography : BMC·Andreas SchmidtBurkhard Hinz
Mar 26, 2010·Journal of Cellular Biochemistry·Xiang-Shu XianJae Myung Park
Sep 6, 2005·Free Radical Biology & Medicine·Mei-Hua LiYoung-Joon Surh
Sep 4, 2015·Biochimica Et Biophysica Acta·M AlmadaN Teixeira
May 11, 2015·Human Reproduction Update·Thangesweran AyakannuJustin C Konje
Apr 14, 2016·Expert Opinion on Therapeutic Targets·Robert Ramer, Burkhard Hinz
Jun 30, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Simona Pisanti, Maurizio Bifulco
Jun 30, 2007·Biochemical and Biophysical Research Communications·Burkhard HinzRudolf Bauer
Aug 15, 2013·Journal of Lipid Research·Robert RamerBurkhard Hinz
Apr 18, 2018·British Journal of Pharmacology·Ana Isabel Fraguas-SánchezAna Isabel Torres-Suárez
Jul 19, 2018·British Journal of Pharmacology·Burkhard Hinz, Robert Ramer
Oct 21, 2018·Journal of Cellular Physiology·Nasser Hashemi GoradelKeywan Mortezaee
Oct 31, 2018·Drugs·Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez
Nov 29, 2007·American Journal of Physiology. Endocrinology and Metabolism·Murray D MitchellMichelle Glass
Nov 6, 2009·The Journal of Pharmacology and Experimental Therapeutics·Nadine FreimuthBurkhard Hinz
Dec 27, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robert RamerBurkhard Hinz
Aug 4, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Burkhard HinzKay Brune
Jan 26, 2011·Annals of the New York Academy of Sciences·Hung-Yun LinPaul J Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis